Breast screening 'does not save lives'

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Breast cancer screening is "unjustified" and may lead to unnecessary aggressive treatment such as surgery, a study published today suggests.

Breast cancer screening is "unjustified" and may lead to unnecessary aggressive treatment such as surgery, a study published today suggests.

There is "no reliable evidence" that screening saves lives and it could increase the number of mastectomies (surgery to remove a woman's breasts) by 20 per cent, two Danish scientists claim.

They conducted a second review of the effectiveness of mammography because their first analysis, published in The Lancet in January of last year, was widely criticised. After re-examining the data, using a more rigorous technique, Dr Peter Gotszsche and Ole Olson said the results "confirmed and strengthened" their original conclusion.

But British cancer experts say this second study was as flawed as the first. A spokesman for the NHS breast cancer screening programme said screening was saving the lives of about 1,250 women and detecting 9,500 cancers a year.

The researchers, from the Nordic Cochrane Centre in Copenhagen, argue that screening identifies slow-growing tumours and other benign cell irregularities that do not threaten a woman's health.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in